Annual EBIT
-$15.57 M
-$7.35 M-89.43%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual earnings before interest & taxes is -$15.57 million, with the most recent change of -$7.35 million (-89.43%) on December 31, 2023.
- During the last 3 years, IMMX annual EBIT has fallen by -$14.54 million (-1414.06%).
- IMMX annual EBIT is now -1748.40% below its all-time high of -$842.30 thousand, reached on December 31, 2019.
Performance
IMMX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$7.39 M
-$2.69 M-57.25%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly earnings before interest & taxes is -$7.39 million, with the most recent change of -$2.69 million (-57.25%) on September 30, 2024.
- Over the past year, IMMX quarterly EBIT has dropped by -$2.87 million (-63.47%).
- IMMX quarterly EBIT is now -8008.44% below its all-time high of -$91.20 thousand, reached on September 30, 2020.
Performance
IMMX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.49 M
-$2.87 M-14.63%
September 30, 2024
Summary
- As of February 12, 2025, IMMX TTM earnings before interest & taxes is -$22.49 million, with the most recent change of -$2.87 million (-14.63%) on September 30, 2024.
- Over the past year, IMMX TTM EBIT has dropped by -$7.93 million (-54.47%).
- IMMX TTM EBIT is now -24561.51% below its all-time high of -$91.20 thousand, reached on September 30, 2020.
Performance
IMMX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMMX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.4% | -63.5% | -54.5% |
| 3 y3 years | -1414.1% | -63.5% | -54.5% |
| 5 y5 years | -1748.4% | -63.5% | -54.5% |
IMMX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.4% | +35.7% | -456.0% | +67.4% | -173.7% | +17.1% |
| 5 y | 5-year | -1748.4% | +35.7% | -8008.4% | +67.4% | <-9999.0% | +17.1% |
| alltime | all time | -1748.4% | +35.7% | -8008.4% | +67.4% | <-9999.0% | +17.1% |
Immix Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.39 M(+57.3%) | -$22.49 M(+14.6%) |
| Jun 2024 | - | -$4.70 M(-15.9%) | -$19.62 M(+5.3%) |
| Mar 2024 | - | -$5.59 M(+16.4%) | -$18.64 M(+19.7%) |
| Dec 2023 | -$15.57 M(+89.4%) | -$4.80 M(+6.2%) | -$15.57 M(+6.9%) |
| Sep 2023 | - | -$4.52 M(+21.6%) | -$14.56 M(+25.8%) |
| Jun 2023 | - | -$3.72 M(+47.6%) | -$11.57 M(+23.0%) |
| Mar 2023 | - | -$2.52 M(-33.6%) | -$9.41 M(+14.5%) |
| Dec 2022 | -$8.22 M | -$3.79 M(+147.5%) | -$8.22 M(-69.7%) |
| Sep 2022 | - | -$1.53 M(-1.8%) | -$27.13 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$1.56 M(+17.4%) | -$25.95 M(+5.7%) |
| Mar 2022 | - | -$1.33 M(-94.1%) | -$24.54 M(+1.4%) |
| Dec 2021 | -$24.20 M(+2253.2%) | -$22.71 M(+6425.7%) | -$24.20 M(+991.3%) |
| Sep 2021 | - | -$348.00 K(+127.2%) | -$2.22 M(+13.1%) |
| Jun 2021 | - | -$153.20 K(-84.5%) | -$1.96 M(+8.5%) |
| Mar 2021 | - | -$987.50 K(+35.5%) | -$1.81 M(+120.5%) |
| Dec 2020 | -$1.03 M(+22.1%) | -$728.60 K(+698.9%) | -$819.80 K(+798.9%) |
| Sep 2020 | - | -$91.20 K | -$91.20 K |
| Dec 2019 | -$842.30 K | - | - |
FAQ
- What is Immix Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Immix Biopharma?
- What is Immix Biopharma annual EBIT year-on-year change?
- What is Immix Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Immix Biopharma?
- What is Immix Biopharma quarterly EBIT year-on-year change?
- What is Immix Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Immix Biopharma?
- What is Immix Biopharma TTM EBIT year-on-year change?
What is Immix Biopharma annual earnings before interest & taxes?
The current annual EBIT of IMMX is -$15.57 M
What is the all time high annual EBIT for Immix Biopharma?
Immix Biopharma all-time high annual earnings before interest & taxes is -$842.30 K
What is Immix Biopharma annual EBIT year-on-year change?
Over the past year, IMMX annual earnings before interest & taxes has changed by -$7.35 M (-89.43%)
What is Immix Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of IMMX is -$7.39 M
What is the all time high quarterly EBIT for Immix Biopharma?
Immix Biopharma all-time high quarterly earnings before interest & taxes is -$91.20 K
What is Immix Biopharma quarterly EBIT year-on-year change?
Over the past year, IMMX quarterly earnings before interest & taxes has changed by -$2.87 M (-63.47%)
What is Immix Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of IMMX is -$22.49 M
What is the all time high TTM EBIT for Immix Biopharma?
Immix Biopharma all-time high TTM earnings before interest & taxes is -$91.20 K
What is Immix Biopharma TTM EBIT year-on-year change?
Over the past year, IMMX TTM earnings before interest & taxes has changed by -$7.93 M (-54.47%)